AQST - Aquestive Therapeutics weighs raising 2023 outlook
2023-10-09 10:20:46 ET
More on Aquestive Therapeutics
- ARS Pharmaceuticals Vs. Aquestive Therapeutics; Neffy CRL Creates An Opportunity For Investing In Both
- Aquestive Therapeutics, Inc. (AQST) Q2 2023 Earnings Call Transcript
- Aquestive Therapeutics, Inc. 2023 Q2 - Results - Earnings Call Presentation
- Aquestive spikes as FDA rejects ARS Pharma’s epinephrine spray
- Seeking Alpha’s Quant Rating on Aquestive Therapeutics
For further details see:
Aquestive Therapeutics weighs raising 2023 outlook